MC
BIOSU

Meteora Capital’s BioPlus Acquisition Corp. Unit BIOSU Stock Holding History

Meteora Capital’s Portfolio BIOSU Stock Details BIOSU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-10,056
Closed -$99K – 463
2022
Q2 		$99K Buy
+10,056
New +$101K 0.02% 312

Other funds holding BIOSU

Calamos Advisors
Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return
HIM
HGC Investment Management Toronto, Ontario, Canada $507M AUM 6.15% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
WC
Wealthspring Capital West Harrison, New York $448M AUM 8.38% 1-Year Est. Return
SIA
Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.73% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2.1B AUM 2.15% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
BCL
Bracebridge Capital LLC Boston, Massachusetts $5.53B AUM 25.79% 1-Year Est. Return
CSS
Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return
LCM
Landscape Capital Management Englewood, New Jersey $1.54B AUM 30.95% 1-Year Est. Return

Meteora Capital's BIOSU Position: Q3 2022 in Review

Meteora Capital sold out of BioPlus Acquisition Corp. Unit (BIOSU) in Q3 2022, closing a stake of 10,056 shares — an estimated $99K sold.

Meteora Capital first reported a position in BIOSU in Q2 2022 and held it in 1 quarter. The position peaked at $99K in Q2 2022. 15 funds tracked by Wall St. Rank hold BIOSU as of Q3 2022.

  • Meteora Capital reported no remaining BioPlus Acquisition Corp. Unit position as of Q3 2022 after selling out during the quarter.
  • Meteora Capital sold 10,056 BioPlus Acquisition Corp. Unit shares in Q3 2022, an estimated $99K.
  • Meteora Capital first reported a position in BioPlus Acquisition Corp. Unit in Q2 2022 and held it in 1 quarter.
  • Meteora Capital's BioPlus Acquisition Corp. Unit position peaked at $99K in Q2 2022.
  • 15 funds tracked by Wall St. Rank held BioPlus Acquisition Corp. Unit as of Q3 2022.

Based on Meteora Capital's 13F filing for Q3 2022, filed 14 Nov 2022.